Discover what automation means for industry capability in 2026, including key benefits and emerging technologies.

Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation, AI, and real-time process control. Image ...

KITCHENER, Ontario & United Kingdom, July 24, 2025--(BUSINESS WIRE)--An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The ...

Labman recently announced its part in the UK Government’s newly announced multi-million-pound investment to speed up advanced science, engineering, biology, and cutting-edge drug manufacturing. With ...

KITCHENER, Ontario & United Kingdom — An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor ...

With over 150,000 new materials developed by the Materials Project computers, Berkeley Lab, headquartered in California, could not synthesize these novel materials quickly enough to evaluate them for ...

An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive ...

Article ‘Count’ and ‘Share’ for Labman Automation Ltd. based on listed parameters only. The articles listed below published by authors from Labman Automation Ltd., organized by journal and article, ...